Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

E. Merck continues to investigate angiotensin II blockers

May 10, 1996

Servier develops S-18149 as putative venotropic agent

May 3, 1996

CPC-111 enters phase II for angioplasty indication

May 3, 1996

Nasal propranolol claimed by RiboGene for angina Rx

May 3, 1996

Novel PAI-1 inhibitor protects against vascular lesions

May 3, 1996

TEI-9063 structure linked to new patent

May 3, 1996

AHP claims smooth muscle cell proliferation inhibitors for restenosis

May 3, 1996

Discovery Therapeutics reports on WRC-0571

May 3, 1996

ATP-sensitive K channel opener reported by Chinese academics

May 3, 1996

Ajinomoto reports on antihypertensive agent AP-1067

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...